Evidence map›Paper›PMID 41347866›Full record

ArticleACS biomaterials science & engineering2026

Plasmid DNA Delivery Using a Stable Nanovesicle Platform: A Design-of-Experiments-Guided Investigation.

Mariana Köber, Irene González-Domínguez, Diego Valdospinos, Eduard Puente-Massaguer, Júlia Piqué-Ponti, David Piña, Laia Avilés-Domínguez, Ariadna Boloix, Miguel F Segura, Nora Ventosa and 1 more

Abstract read
In one paragraph

Article in ACS biomaterials science & engineering, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Mariana KöberInstitute of Materials Science of Barcelona (ICMAB-CSIC), Universitat Autònoma de Barcelona, Cerdanyola del Vallès, 08193 Barcelona, Spain.ORCID 0000-0001-9962-7900
Irene González-DomínguezDepartament d'Enginyeria Química Biològica i Ambiental, Universitat Autònoma de Barcelona, Cerdanyola del Vallès, 08193 Barcelona, Spain.
Diego ValdospinosInstitute of Materials Science of Barcelona (ICMAB-CSIC), Universitat Autònoma de Barcelona, Cerdanyola del Vallès, 08193 Barcelona, Spain.
Eduard Puente-MassaguerDepartament d'Enginyeria Química Biològica i Ambiental, Universitat Autònoma de Barcelona, Cerdanyola del Vallès, 08193 Barcelona, Spain.ORCID 0000-0002-2816-7051
Júlia Piqué-PontiInstitute of Materials Science of Barcelona (ICMAB-CSIC), Universitat Autònoma de Barcelona, Cerdanyola del Vallès, 08193 Barcelona, Spain.
David PiñaInstitute of Materials Science of Barcelona (ICMAB-CSIC), Universitat Autònoma de Barcelona, Cerdanyola del Vallès, 08193 Barcelona, Spain.
Laia Avilés-DomínguezInstitute of Materials Science of Barcelona (ICMAB-CSIC), Universitat Autònoma de Barcelona, Cerdanyola del Vallès, 08193 Barcelona, Spain.
Ariadna BoloixChildhood Cancer and Blood Disorders Group, Vall d'Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona, 08035 Barcelona, Spain.ORCID 0000-0002-1648-5589
Miguel F SeguraChildhood Cancer and Blood Disorders Group, Vall d'Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona, 08035 Barcelona, Spain.
Nora VentosaInstitute of Materials Science of Barcelona (ICMAB-CSIC), Universitat Autònoma de Barcelona, Cerdanyola del Vallès, 08193 Barcelona, Spain.ORCID 0000-0002-8008-4974
Francesc GòdiaDepartament d'Enginyeria Química Biològica i Ambiental, Universitat Autònoma de Barcelona, Cerdanyola del Vallès, 08193 Barcelona, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Delivering plasmid DNA (pDNA) into cells is essential for numerous biotechnological and biomedical applications. Among available nanocarriers, nonviral lipid-based vesicles are particularly promising for transfecting mammalian cells. Nevertheless, further development is required to create delivery systems that are both broadly effective across cell types and scalable for clinical use. Here, we explore stable nanovesicles composed of the sterol derivative cholesteryl

Indexed as

DNANanoparticlesPlasmidsTransfectionCholesterolGene Transfer TechniquesGreen Fluorescent ProteinsHEK293 CellsHumansCholesterolDNAGreen Fluorescent ProteinsDesign of Experimentsgreen fluorescent proteinHEK293 cell transfectionlipid-based nanovesiclesnonviral vectorsplasmid DNA deliveryquatsomes

Identifiers

PMID41347866
PMCPMC12801183

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.